“…Higher hazard of mortality was found among males (aHR: 2.014 [95% CI: 1.186–3.418, P = 0.010]). Patients with respiratory and other types of comorbidities and cancer had a higher mortality hazard (aHR: 1.898 [95% CI: 1.005–3.582, P = 0.048]; aHR: 2.346 [95% CI: 1.313–4.192, P = 0.004]; aHR: 3.292 [95% CI: 1.804–6.006, P = 0.001]), respectively. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…PARTICIPANTS: Long-stay (≥60 days) care clients (n=153 125) aged ≥50 years assessed between April 2014 and March 2015. MAIN OUTCOME MEASURES: Dementia was ascertained with a validated administrative data algorithm and frailty with a 66-item frailty index (FI) based on a previously validated FI derived from the clinical assessment. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: This was a multi-institutional retrospective study of all adults (≥18) with BSI who were initially managed non-operatively between 2014 and 2016. Multivariate logistic regression analysis was used to identify predictors of SAE by OIS grade. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…After adjusting for the potential confounding factors of the injury severity score, age, sex, Glasgow coma scale score, systolic blood pressure, trauma etiology (blunt or penetrating), and admission phase (2002–2005, 2006–2009, 2010–2013, and 2014–2018), no statistically significant association was present between first-quartile admission and trauma death (adjusted OR 0.980; 95% CI 0.748–1.284). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study used data collected nationally from Medicare and the Veterans Health Administration for care provided in fiscal years 2010 to 2014. Participants were 48 937 adults aged 66 years or older who died of solid tumor and were continuously enrolled in fee-for-service Medicare and the Veterans Health Administration in the 12 months prior to death. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The following was collected: demographics, past medical history, medications, WBC, maximum temperature, time to defervescence, etiology of T ≥ 104, and death. RESULTS: Less than 0.01% of all patient encounters were associated with T ≥ 104. …”
Enlace del recurso
Enlace del recurso

“…METHODS: We used data of 12,145 patients with STEMI who was registered in China Acute Myocardial Infarction registry from January 2013 to September 2014. We compared the infarct-related artery (IRA), thrombolysis in myocardial infarction (TIMI) flow grade in the IRA, and other angiographic characteristics between patients without and those with chest pain. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…PARTICIPANTS: A total of 9932 patients undergoing incident CRC surgery during 2005–2014 in northern Denmark were included through the Danish Colorectal Cancer Group Database. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Key outcomes included time to cohort treatment failure, time to index AED treatment failure, and direct healthcare costs in 2014 Pound Sterling (£) values. RESULTS: Overall, 1425 elderly patients were included: 964 with EIAEDs and 461 with nEAAEDs. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: We identified a total of 75 patients diagnosed with KRAS-mutant (determined by molecular sequencing) advanced NSCLC between 2014/5/9 and 2019/5/30. KRAS mutation subtypes were divided into G12C and non-G12C groups for statistical analysis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Participants were followed from 01/01/2014 to advanced CKD, loss to follow-up, death, or end of the study period (12/31/2017), whichever came first. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Registered on 25 July 2014.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS AND FINDINGS: Granulocyte (innate immunity) and lymphocyte (adaptive immunity) counts were determined 3 times (2002–2008, mean age 65.2 years; 2009–2013, mean age 69.0 years; and 2014–2015, mean age 78.5 years) in participants of the population-based Rotterdam Study without ASCVD at baseline. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Methods: Patients diagnosed with differentiated thyroid cancer in 2014–2015 from the Surveillance, Epidemiology and End Results Program (SEER) registries of Georgia and Los Angeles County were asked to identify endocrinologists and surgeons involved in managing their thyroid cancer. …”
Enlace del recurso
Enlace del recurso

“…We also examined all-cause death as a secondary outcome to discuss potential competing risk of mortality in the association between CKD and dementia diagnosis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: This was an observational study using French National Health System claims data and including all adults with nonvalvular atrial fibrillation who initiated oral anticoagulant between 2014 and 2016. Outcomes of interest were major bleeding events leading to hospitalization (safety), stroke and systemic thromboembolic events (effectiveness), and all-cause mortality. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…We identified T2D patients who received new prescription of SGLT2i or GLP-1RA from 2014 to 2018. SGLT2i and GLP-1RA initiators were matched 1:1 by propensity scores. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: Among patients diagnosed with ovarian cancer in the Women’s Hospital School of Medicine, Zhejiang University between January 2014 and May 2019, 328 patients were included in a K-mean cluster analysis and 176 patients followed up. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: Totally, 8830 patients who were diagnosed of mucinous breast carcinoma between 2004 and 2014 from SEER database were reviewed retrospectively. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Treatment-naïve patients with locally advanced or metastatic NSCLC were enrolled from January to December 2014. The following data were collected from the medical records of patients from diagnosis until the last record (death, loss to follow-up, or the end of the maximum follow-up period): demographics; medical history; smoking status; disease characteristics; previous treatments; and molecular testing patterns and results. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso